TuisFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Vorige sluiting
$9,02
Dagwisseling
$8,79 - $9,44
Jaarwisseling
$8,79 - $14,03
Markkapitalisasie
2,68 mjd USD
Gemiddelde volume
2,42 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 141,52 m | 36,73% |
Bedryfskoste | 103,44 m | -4,74% |
Netto inkomste | -6,73 m | 68,81% |
Netto winsgrens | -4,75 | 77,22% |
Wins per aandeel | 0,10 | 242,86% |
EBITDA | 26,97 m | 310,72% |
Effektiewe belastingkoers | 199,17% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 249,76 m | -10,90% |
Totale bates | 786,56 m | 2,94% |
Totale aanspreeklikheid | 607,73 m | -3,66% |
Totale ekwiteit | 178,82 m | — |
Uitstaande aandele | 298,81 m | — |
Prys om te bespreek | 15,03 | — |
Opbrengs op bates | 8,07% | — |
Opbrengs op kapitaal | 10,33% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -6,73 m | 68,81% |
Kontant van bedrywe | -22,97 m | 40,10% |
Kontant van beleggings | 34,27 m | -4,17% |
Kontant van finansiering | 18,19 m | -51,65% |
Netto kontantverandering | 24,46 m | -52,90% |
Beskikbare kontantvloei | -28,79 m | -466,77% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
517
